Skip Navigation

The University of Texas Southwestern Medical Center

Location

The University of Texas Southwestern Medical Center
Southwestern Medical Center at Dallas
2201 Inwood Rd
Suite NC2.130
Dallas, TX 75390-8562
Direct phone: (214) 645-HOPE (4673)
Toll-free: (866) 460-HOPE (4673)

Total transplants by cell source

From January 1, 2020 to December 31st, 2021
  • Marrow: 7
  • PBSC: 64
  • Cord Blood: 0
  • Autologous (PBSC or Marrow): 194
Performs adult transplants

Overview

The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center is one of the nation's leading programs for hematologic malignancies. With a focus on excellence and compassion, our physicians and staff manage patients at all stages of their care. The program has an excellent track record in the delivery of state-of-the-art transplants. In addition, the program features an active translational research component that aims to improve transplant results by applying recent advances in immunobiology to the clinic.

This center has been performing allogeneic transplants since 1999 and has been an NMDP/Be The Match transplant center since December 2001.

Attending physicians

Adult - Aimaz Afrough , Julio Alvarenga, Larry Anderson, Farrukh Awan, Stephen Chung, Robert Collins, Vivian Irizarry, Clayton Jackson, Gurbakhash Kaur, Adeel Khan, Yazan Madanat, Alejandro Marinos, Praveen Ramakrishnan, Heather Wolfe, Elif Yilmaz

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on

Adult only

Other programs and services

As part of the only National Cancer Institute-designated Comprehensive Cancer Center in North Texas, The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwestern Medical Center is able to offer referring physicians and patients a range of services unsurpassed in the region, including:
• Diagnosis and treatment of all hematologic malignancies
• Stem cell transplantation - autologous, allogeneic related and unrelated, cord blood, haploidentical)
• Investigational therapy
• Specialized center for acute myeloid leukemia and myelodysplastic syndrome, plasma cell neoplasms (multiple myeloma, Waldenstroms macroglobulinemia, and amyloidosis), chronic lymphocytic leukemia, and acute lymphoblastic leukemia
• Familial malignancies clinic
• Cutaneous T-cell lymphoma clinic
• CNS lymphoma clinic
• Chronic GVHD (graft-versus-host disease) clinic
• Survivorship clinic
• Comprehensive second opinion service
• Nationally renowned hematopathology (microscopy, flow cytometry, cytogenetics, molecular diagnostics)
• In-depth genetic and functional screening of patients with relapsed/refractory malignancies, allowing for individualized molecular-targeted therapy

About the center

Overview

The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center is one of the nation's leading programs for hematologic malignancies. With a focus on excellence and compassion, our physicians and staff manage patients at all stages of their care. The program has an excellent track record in the delivery of state-of-the-art transplants. In addition, the program features an active translational research component that aims to improve transplant results by applying recent advances in immunobiology to the clinic.

This center has been performing allogeneic transplants since 1999 and has been an NMDP/Be The Match transplant center since December 2001.

Attending physicians

Adult - Aimaz Afrough , Julio Alvarenga, Larry Anderson, Farrukh Awan, Stephen Chung, Robert Collins, Vivian Irizarry, Clayton Jackson, Gurbakhash Kaur, Adeel Khan, Yazan Madanat, Alejandro Marinos, Praveen Ramakrishnan, Heather Wolfe, Elif Yilmaz

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on

Adult only

Other programs and services

As part of the only National Cancer Institute-designated Comprehensive Cancer Center in North Texas, The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwestern Medical Center is able to offer referring physicians and patients a range of services unsurpassed in the region, including:
• Diagnosis and treatment of all hematologic malignancies
• Stem cell transplantation - autologous, allogeneic related and unrelated, cord blood, haploidentical)
• Investigational therapy
• Specialized center for acute myeloid leukemia and myelodysplastic syndrome, plasma cell neoplasms (multiple myeloma, Waldenstroms macroglobulinemia, and amyloidosis), chronic lymphocytic leukemia, and acute lymphoblastic leukemia
• Familial malignancies clinic
• Cutaneous T-cell lymphoma clinic
• CNS lymphoma clinic
• Chronic GVHD (graft-versus-host disease) clinic
• Survivorship clinic
• Comprehensive second opinion service
• Nationally renowned hematopathology (microscopy, flow cytometry, cytogenetics, molecular diagnostics)
• In-depth genetic and functional screening of patients with relapsed/refractory malignancies, allowing for individualized molecular-targeted therapy

Overall center survival


Patient survival information for this center

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 111 patients.

The actual 1-year survival of these patients is 74.8%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 66.4% and 82.0%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

Total transplants

Total transplants


265

Transplants reported (From January 1, 2020 to December 31st, 2021 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 2 27 0 29
Unrelated donor 5 37 0 42
Total allogeneic 7 64 0 71
Autologous
Both marrow & PBSC
194
-- 194
Total combined
265 0 265

Transplants by disease

All diseases

Number of transplants by age reported from January 1, 2020 to December 31st, 2021 (includes marrow, PBSC and cord blood)

0-18 19-44 45-64 65+ Total
Related 0 14 6 9 29
Unrelated 0 11 18 13 42
Autologous 0 24 91 79 194
Total 0 49 115 101 265

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants for this disease can be found:

Additional information

Transplant center resources

Transplant center coordinator:
Christen Bennett
(214) 645-2619
Email: christen.bennett@utsouthwestern.edu

Financial representative:
Helen Edwards
(214) 648-7028
Email: helen.edwards@utsouthwestern.edu

Be The Match patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743

Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

Survivorship program

Loading survivorship program information...